Sabitlenmiş Tweet
We are honored to be featured in the top 5 of NZ's hottest biotech startups! Big thanks to @businessdesk_nz
businessdesk.co.nz/article/the-fi…
English
Amaroq Therapeutics
53 posts
Amaroq Therapeutics
@amaroqtx
Nothing remains concealed. Exploring long #noncoding #RNAs in #cancer. Founded by @oncogenie
Katılım Ekim 2020
37 Takip Edilen185 Takipçiler
Thanks so much for including us in this panel!
#QRW2023
Tim Woodfield@Tim_WoodfieldNZ
Great to moderate the Research Commercialisation workshop @QTResearchWeek supported by @otago Centre for Bioengineering with expert panel: Sarah Diermeier @amaroqtx Elliot Dunn #brandoncapital Kathleen Lucere #EvenCapital Sam Wilkins @OtagoInnovation Azam Ali @otago @MedtechNZ
English
Exciting updates on AURORA our oncology target ID platform!
Check out our webpage and LinkedIn for details linkedin.com/posts/amaroqtx…
English
Amaroq Therapeutics retweetledi
Interesting talk by Sarah Diermeier from @amaroqtx on developing a new class of therapeutics that target long non-coding RNAs in cancer
#ShineDalgarnoCentre #ANURNA2023 #SDCRI @JCSMR
English
Amaroq Therapeutics retweetledi
English
Great to see our Founder and CSO Sarah Diermeier featured for #WomensHistoryMonth in @NatureBiotech!
Nature Biotechnology@NatureBiotech
For #WomensHistoryMonth, we're celebrating outstanding scientists in the biotech industry. We salute Sarah Diermeier, founder and chief scientific officer of Amaroq Therapeutics, which is focused on developing a new class of therapeutics that target long non-coding RNAs in cancer
English
As another recent addition to the team, we are welcoming @KLucere!
Kat comes with a deep tech background (cancer research and neurobiology) in both US and NZ science ecosystems. She is now doing a stellar job supporting our BD efforts.
We are so excited to have you Kat!
English
Amaroq Therapeutics retweetledi
So excited to have joined the team and be working on this amazing technology!
Amaroq Therapeutics@amaroqtx
We made some recent additions to our team! We were lucky to recruit the amazing @MMROMalley, an RNA Tx and oncology expert, to lead our in vitro TIDVAL efforts. Welcome Meg, we look forward to developing the next generation of cancer drugs together!
English
Grateful to have had the opportunity to attend and present my research at #cshlcancer22 this past week.
Met some amazing people, heard about fantastic science and ofc the highlight was the famous CSHL lobster!! 🦞
English
@MMROMalley Great to hear you enjoyed the meeting (and lobster) @CSHL!
English
We made some recent additions to our team!
We were lucky to recruit the amazing @MMROMalley, an RNA Tx and oncology expert, to lead our in vitro TIDVAL efforts.
Welcome Meg, we look forward to developing the next generation of cancer drugs together!
English
Amaroq Therapeutics retweetledi
Join us next Monday at a @BIOTechNZ event in Dunedin!
I‘ll be speaking about @amaroqtx alongside the CEO of @PacificEdgeLtd and others in the local biotech sphere
BIOTechNZ@BIOTechNZ
BioTechNZ is proud to announce its next Connect event, Understanding Dunedin’s Flourishing Biotech Ecosystem. Hear from established and start-up companies, learn about their growth and hear how they are accessing funding.ow.ly/uuuE50JzKlg @otago biotechnz.org.nz/event/understa…
English
We are thrilled to announce our recent progress towards the next generation of RNA therapeutics in oncology.
We were also fortunate to assemble a stellar Scientific Advisory Board that will guide us on our path to the clinic!
prnewswire.com/news-releases/…
English
R&D team photo with our Operations Manager Dr Nadine Brew (right), who visited us this week from Melbourne.
Had two productive days of strategic planning to map out the next 12 month’s of our RNA therapeutics development program. Exciting times ahead!
English
Experience in RNA biology and/or drug development is preferred
English
We have some exciting job opportunities coming up🤩
If you are keen to develop the next generation of RNA therapeutics for oncology, please get in touch!
English
Amaroq Therapeutics retweetledi
Research leader pushes nanomedicine hub in NZ ift.tt/tF9Dorj
New Zealand should become a nanomedicine production hub, says an up-and-coming commercial researcher based here at Otago Biochemistry.
Dr Sarah Diermeier, Rutherford Discovery Fellow and senior lecturer, ma…
English
Amaroq Therapeutics retweetledi
Oped by myself and the brilliant Kylie Price, CTO of @Malaghan_Inst on how recent technological advancements in mRNA vaccines and the RNA therapeutics space can benefit the NZ economy
nbr.co.nz/node/234003
English
Amaroq Therapeutics retweetledi
Excited to share that Eclipsebio (co-founded by our lab alums @EVanNostrandLab and Alex Shishkin) announces a $14 Million Series A Financing to Advance Its RNA Genomics Technology Platform prn.to/34IZqSG
English